Wertheimer likens Iscar to Microsoft [pg. 15]

By SHARON WROBEL
June 5, 2006 02:13
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Eitan Wertheimer, the publicity-shy man who convinced investor billionaire Warren Buffett to buy his company for $4 billion, boasted Sunday that Iscar's profitability was like that of software giant Microsoft. Addressing the "Annual Capital Market" conference by The Marker and Brightman Almagor, Wertheimer, who in the past had been quiet about Iscar's profitability, however, did not want to comment on whether the analogy with Microsoft meant that Iscar's profit level was 35 percent of turnover. "But I would say that Buffett commented he'd never seen a company like it," said Wertheimer. "There are no executive employment contracts at Iscar. A handshake is worth more commitment than any document." Wertheimer added that by selling 80% of Iscar, he actually bought a fascinating partner and a gigantic window of opportunity to get things done. Although Buffett has bought the controlling interest in Iscar through a highly complex transaction, the company will continue to pay tax as usual, Wertheimer confirmed. Responding to a question of how he twisted Buffett's arm, Wertheimer said there were important rules to remember. "Don't come to Buffett after you have been to 10 others; be brief; and come with a price and don't waste his time." Wertheimer proudly said Israel has a vast potential with more businesses like Iscar. "But the problem is the speed with which Israeli businesses are run and often they are sold off too early."

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS